AMSTERDAM, The Netherlands, July 29, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the second quarter ended June 28, 2015 after the close of the regular trading market on Wednesday, August 5, 2015. Due to the Company's pending merger with Wright Medical Group, Inc., which, pending FTC clearance, is expected to close in the third quarter, the company will not host an accompanying conference call.
Tornier is a global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company's broad offering of over 100 product lines includes joint replacement, trauma, sports medicine, and biologic products to treat the extremities, as well as joint replacement products for the hip and knee in certain international markets. Since its founding approximately 70 years ago, Tornier's "Specialists Serving Specialists" philosophy has fostered a tradition of innovation, intense focus on surgeon education, and commitment to advancement of orthopaedic technology stemming from its close collaboration with orthopaedic surgeons and thought leaders throughout the world. For more information regarding Tornier, visit www.tornier.com.
CONTACT: Tornier N.V.Shawn McCormick
Chief Financial Officer
News Provided by Acquire Media